Home >Companies >News >AYUSH Ministry’s manufacturing unit IMPCL achieves highest ever turnover of 160 Crore

Reflective of the fast-growing adoption of AYUSH products and services by the public in the wake of covid-19 pandemic, the Indian Medicines Pharmaceutical Corporation Limited (IMPCL), the public sector manufacturing unit of the Ministry of AYUSH has recorded a turnover of 164.33 Crore in 2020-21, the highest in company’s history.

The company also reported an all-time high profit of approximately 12 crore for the year. In the previous year 2019-20 best revenue figures of the company was 97 Crore. The Central Drugs Standards Control organisation (CDSCO) recently recommended its 18 Ayurvedic products for WHO-GMP/COPP certification subject to certain observations in March 2021.

‘World Health Organization, Good Manufacturing Practices / Certificate of Pharmaceutical Product (WHO-GMP/CoPP)’ certification is given to companies after conducting an inspection. This certification is an endorsement of the quality of IMPCL’s products. It will help IMPCL to commence export operation of quality medicines at a global level.

IMPCL is one of the most trusted manufacturers of AYUSH medicines in the country and is known for the authenticity of its formulations. During the COVID-19 pandemic, it was able to cater the needs of the country in the shortest time, probably the first company in the country to provide Immuno boosting medicines as Auraksha Immuno Boosting Kit. At 350, it is one of the lowest-priced such kits and is also available on Amazon. Nearly 2 lakh such kits have been sold in the last two months.

Presently, IMPCL is manufacturing 656 classical Ayurvedic, 332 Unani and 71 proprietary Ayurvedic medicines for the various diseases spectrum. It has contributed towards research and development activities and 25 new proprietary Ayurvedic medicines as per the Essential Drug List (EDL).

Every Government institution doing business with IMPCL has praised the company for providing steady support to various health programmes and ensuring an unbroken supply of products during the covid-19 pandemic.

“IMPCL has always been regarded as a benchmark institution for quality among the manufacturers of Indian medicines. The steadily growing turnover in the last few years, especially the spurt in the last year, indicates it has won the trust of the public," said P N Ranjit Kumar, joint secretary and spokesperson, Ministry of AYUSH.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

Edit Profile
My ReadsRedeem a Gift CardLogout